Literature DB >> 6255770

The chemotherapeutic exploitation of virus-specified enzymes.

G B Elion.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6255770     DOI: 10.1016/0065-2571(80)90008-4

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


× No keyword cloud information.
  5 in total

Review 1.  Gene therapy. Clinical potential and relationship to drug treatment.

Authors:  K A Whartenby; A J Marrogi; S M Freeman
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

2.  Influence of acyclovir and bucyclovir on nucleotide pools in cells infected with herpes simplex virus type 1.

Authors:  A H Karlsson; J G Harmenberg; B E Wahren
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Specific oncolytic activity of herpesvirus saimiri in pancreatic cancer cells.

Authors:  A J Stevenson; M S Giles; K T Hall; D J Goodwin; M A Calderwood; A F Markham; A Whitehouse
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

4.  Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.

Authors:  Lei-qing Li; Fang Shen; Xiao-yan Xu; Hong Zhang; Xiao-feng Yang; Wei-guo Liu
Journal:  ScientificWorldJournal       Date:  2013-03-03

5.  The role of herpes simplex virus-1 thymidine kinase alanine 168 in substrate specificity.

Authors:  Willmon Candice L; Sussman Django; Black Margaret E
Journal:  Open Biochem J       Date:  2008-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.